The understanding of efficient chiral syntheses is important in the development of the pharmaceutical industry.The discovery and subsequent investigations of the RuBINAP catalyst for the simple synthesis of thenonsteroidal antiinflammatory drug (NSAID) naproxen is an example of a practical application of chiralsynthesis, although there is little published information on the reaction kinetics. The aim of this study was toprovide kinetic and enantioselectivity data and the Arrhenius parameters for kinetics over a range oftemperatures and H
2 pressures under H
2 mass-transfer-free conditions. An additional aim was to investigatethe effect of TEA on the reaction rate, which has not been investigated previously for this substrate. Thestudy is innovative in that it uses in situ UV-vis spectroscopy to investigate the reaction kinetics, providingsome significant advantages over intrusive sampling techniques. The study confirmed available literaturevalues and demonstrated that, under a substrate/TEA ratio of 1, the maximum H
2 pressure required at 25
Cwas only 30 bar to achieve a maximum reaction rate and enantioselectivity. TEA was shown to significantlyretard the reaction rate, indicating that there is an optimum TEA/H
2 ratio in rate and enantioselectivity.